What are the potential consequences of AstraZeneca’s Covishield in causing blood clots
Delve into the medical concerns surrounding Covishield and its impact on blood clotting.
1. AstraZeneca's Covishield may cause blood clots, specifically cerebral venous sinus thrombosis (CVST) and other rare clotting disorders.
2. The risk of blood clots appears to be higher in younger individuals, particularly women under 60 years of age.
3. Symptoms of blood clots include persistent headaches, blurred vision, shortness of breath, chest pain, and swelling in the legs.
4. The potential consequences of blood clots from Covishield can be serious, including stroke, heart attack, or even death in rare cases.
5. Health authorities recommend monitoring for post-vaccination symptoms and seeking medical attention if any concerning signs of blood clots arise.
6. Individuals should consult healthcare professionals for personalized advice on the benefits and risks of receiving the Covishield vaccine.
Answered
a year ago